{
  "type": "ref",
  "text": "sustained NF-kappaB activity by Tat in presence of newly synthesized IkappaB-alpha; (ii) coimmunoprecipitation of Tat with IkappaB-alpha and p65;\n",
  "self": {
    "NER": {
      "answers": [
        "Tat",
        "Tat"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the main component of the NF-kappaB activity?",
          "What is the main component of the NF-kappaB activity?"
        ]
      }
    },
    "NOUN": {
      "answers": [
        "Tat",
        "presence",
        "newly synthesized IkappaB-alpha",
        "Tat",
        "IkappaB-alpha",
        "p65"
      ],
      "QG_hash=ThomasNLG/t5-qg_squad1-en": {
        "questions": [
          "What is the main component of the NF-kappaB activity?",
          "What is the main factor that causes Tat to be able to sustain NF-kapp",
          "What is the main component of the NF-kappaB activity?",
          "What is the main component of the NF-kappaB activity?",
          "What is the name of the protein that is used to synthesize Tat?",
          "What is the name of the protein that is coimmunoprecipitated with"
        ]
      }
    }
  },
  "asked": {
    "What was the ratio of p65 protein to IkappaB-alpha?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.004073739051818848,
        "ground_truth": {
          "1:200": {
            "bertscore": 0.670195460319519,
            "f1": 0
          }
        }
      }
    },
    "What type of cells showed a halved p65 protein?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0011071562767028809,
        "ground_truth": {
          "Tat-positive": {
            "bertscore": 0.6908117532730103,
            "f1": 0
          },
          "Tat-positive cells": {
            "bertscore": 0.6433505415916443,
            "f1": 0
          }
        }
      }
    },
    "What is the lanes 1 and 3 of the figure showing the dose-dependent binding of": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.03237837553024292,
        "ground_truth": {
          "4D": {
            "bertscore": 0.6935383677482605,
            "f1": 0
          }
        }
      }
    },
    "What was the dose-dependent binding of p65?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0062566399574279785,
        "ground_truth": {
          "1": {
            "bertscore": 0.7022401690483093,
            "f1": 0
          }
        }
      }
    },
    "What is the number of lanes in the 4D model?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0004762411117553711,
        "ground_truth": {
          "3": {
            "bertscore": 0.6802684664726257,
            "f1": 0
          }
        }
      }
    },
    "What protein coimmunoprecipitated with IkappaB-al": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "Tat",
        "answerability": 0.5934955477714539,
        "ground_truth": {
          "Tat": {
            "bertscore": 1.0000001192092896,
            "f1": 1.0
          }
        }
      }
    },
    "What is the lanes 4 and 4 of the Figure 4D?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.001958608627319336,
        "ground_truth": {
          "4E": {
            "bertscore": 0.7047508955001831,
            "f1": 0
          }
        }
      }
    },
    "What is the lanes of the p65 protein in Figure 4D?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0016220808029174805,
        "ground_truth": {
          "4": {
            "bertscore": 0.6834468841552734,
            "f1": 0
          }
        }
      }
    },
    "What was coimmunoprecipitated with IkappaB-al": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.42960256338119507,
        "ground_truth": {
          "The p65 protein": {
            "bertscore": 0.6204043030738831,
            "f1": 0
          }
        }
      }
    },
    "What protein was p65 coimmunoprecipitated with?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.27728039026260376,
        "ground_truth": {
          "IkappaB-alpha": {
            "bertscore": 0.6390498280525208,
            "f1": 0
          }
        }
      }
    },
    "What is the lanes 1 and 3 of the figure showing that Tat competed with Ik": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.0560266375541687,
        "ground_truth": {
          "Figure 4D": {
            "bertscore": 0.6680412292480469,
            "f1": 0
          }
        }
      }
    },
    "How did Tat compete with IkappaB-alpha binding to p65?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.2508414387702942,
        "ground_truth": {
          "a dose-dependent manner": {
            "bertscore": 0.6532402038574219,
            "f1": 0
          }
        }
      }
    },
    "What is the lanes 4 and 4 of the figure?": {
      "QA_hash=ThomasNLG/t5-qa_squad2neg-en": {
        "answer": "unanswerable",
        "answerability": 0.002833425998687744,
        "ground_truth": {
          "Figure 4E": {
            "bertscore": 0.6712117791175842,
            "f1": 0
          }
        }
      }
    }
  }
}